Global Alcohol Addiction Therapeutics Market By Product Type (CM-1212, CTDP-002) And By End-Users/Application (Hospital, Clinic) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Alcohol Addiction Therapeutics market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Alcohol Addiction Therapeutics market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Alcohol Addiction Therapeutics industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Alcohol Addiction Therapeutics ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Alcohol Addiction Therapeutics market.

The following manufacturers are covered in this report:
  • AstraZeneca Plc
  • BioCorRx Inc
  • Bionex Pharmaceuticals LLC
  • Cerecor Inc
  • Chronos Therapeutics Ltd
  • Corcept Therapeutics Inc
  • Curemark LLC
  • Eli Lilly and Company
  • Ethypharm SA
  • H. Lundbeck A/S
  • Heptares Therapeutics Ltd
  • Indivior Plc
  • Kinnov Therapeutics SAS
  • Kyorin Pharmaceutical Co Ltd
  • Lohocla Research Corp
  • Montisera Ltd
  • Omeros Corp
  • Opiant Pharmaceuticals Inc

The report estimates on the Alcohol Addiction Therapeutics market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Alcohol Addiction Therapeutics market report consist of all leading industry players, Alcohol Addiction Therapeutics business sections, company profile, revenue supply by Alcohol Addiction Therapeutics industry sections, global Alcohol Addiction Therapeutics market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Alcohol Addiction Therapeutics market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Alcohol Addiction Therapeutics market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Alcohol Addiction Therapeutics market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Alcohol Addiction Therapeutics market.

Report Opportunity: Global Alcohol Addiction Therapeutics Market

This report delivers an analytical examination of the Alcohol Addiction Therapeutics market summarized in broad sections such as
  1. Alcohol Addiction Therapeutics Market Summary
  2. Key Commercial Growths in the Alcohol Addiction Therapeutics Industry
  3. Market Dynamics Affecting the Alcohol Addiction Therapeutics Industry
  4. Important Market Trends and Future Development Scenario of the Alcohol Addiction Therapeutics Market
  5. Alcohol Addiction Therapeutics Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Alcohol Addiction Therapeutics Industry
  7. Positioning of Main Market Players in the Alcohol Addiction Therapeutics Industry
  8. Alcohol Addiction Therapeutics Market Revenue and Forecast, by Application, 2018 - 2028
  9. Alcohol Addiction Therapeutics Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Alcohol Addiction Therapeutics Market Revenue and Forecast, by Geography, 2018 - 2028
Alcohol Addiction Therapeutics Market Segmentation:

The report provides detailed examination of the Alcohol Addiction Therapeutics market on the basis of various segments such as type, application and end-use industry. The Alcohol Addiction Therapeutics market is segmented as follows:

Alcohol Addiction Therapeutics Market, by Type:
  • CM-1212
  • CTDP-002
  • A-705253
  • ABT-436
  • ADX-71441
  • Others
Alcohol Addiction Therapeutics Market, by Application:
  • Hospital
  • Clinic
  • Others
Geographic Coverage

The report on the Alcohol Addiction Therapeutics market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Alcohol Addiction Therapeutics Market Revenue and Forecast
  • U.S.
  • Canada
Europe Alcohol Addiction Therapeutics Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Alcohol Addiction Therapeutics Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Alcohol Addiction Therapeutics Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Alcohol Addiction Therapeutics Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Alcohol Addiction Therapeutics Market Snapshot
          2.1.1. Global Alcohol Addiction Therapeutics Market By Type,2019
               2.1.1.1.CM-1212
               2.1.1.2.CTDP-002
               2.1.1.3.A-705253
               2.1.1.4.ABT-436
               2.1.1.5.ADX-71441
               2.1.1.6.Others
          2.1.2. Global Alcohol Addiction Therapeutics Market By Application,2019
               2.1.2.1.Hospital
               2.1.2.2.Clinic
               2.1.2.3.Others
          2.1.3. Global Alcohol Addiction Therapeutics Market By End-use,2019
          2.1.4. Global Alcohol Addiction Therapeutics Market By Geography,2019

3. Global Alcohol Addiction Therapeutics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Alcohol Addiction Therapeutics Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Alcohol Addiction Therapeutics Market Size (US$), By Type, 2018 – 2028

5. Global Alcohol Addiction Therapeutics Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Alcohol Addiction Therapeutics Market Size (US$), By Application, 2018 – 2028

6. Global Alcohol Addiction Therapeutics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Alcohol Addiction Therapeutics Market Size (US$), By End-use, 2018 – 2028

7. Global Alcohol Addiction Therapeutics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Alcohol Addiction Therapeutics Market Analysis, 2018 – 2028 
          7.2.1. North America Alcohol Addiction Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Alcohol Addiction Therapeutics Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Alcohol Addiction Therapeutics Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Alcohol Addiction Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Alcohol Addiction Therapeutics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Alcohol Addiction Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Alcohol Addiction Therapeutics Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Alcohol Addiction Therapeutics Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Alcohol Addiction Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Alcohol Addiction Therapeutics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Alcohol Addiction Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Alcohol Addiction Therapeutics Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Alcohol Addiction Therapeutics Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Alcohol Addiction Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Alcohol Addiction Therapeutics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Alcohol Addiction Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Alcohol Addiction Therapeutics Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Alcohol Addiction Therapeutics Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Alcohol Addiction Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Alcohol Addiction Therapeutics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Alcohol Addiction Therapeutics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Alcohol Addiction Therapeutics Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Alcohol Addiction Therapeutics Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Alcohol Addiction Therapeutics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Alcohol Addiction Therapeutics Providers
        8.4.1 AstraZeneca Plc
                8.1.1 Business Description
                8.1.2 AstraZeneca Plc Geographic Operations
                8.1.3 AstraZeneca Plc Financial Information
                8.1.4 AstraZeneca Plc Product Positions/Portfolio
                8.1.5 AstraZeneca Plc Key Developments
        8.4.2 BioCorRx Inc
                8.2.1 Business Description
                8.2.2 BioCorRx Inc Geographic Operations
                8.2.3 BioCorRx Inc Financial Information
                8.2.4 BioCorRx Inc Product Positions/Portfolio
                8.2.5 BioCorRx Inc Key Developments
        8.4.3 Bionex Pharmaceuticals LLC
                8.3.1 Business Description
                8.3.2 Bionex Pharmaceuticals LLC Geographic Operations
                8.3.3 Bionex Pharmaceuticals LLC Financial Information
                8.3.4 Bionex Pharmaceuticals LLC Product Positions/Portfolio
                8.3.5 Bionex Pharmaceuticals LLC Key Developments
        8.4.4 Cerecor Inc
                8.4.1 Business Description
                8.4.2 Cerecor Inc Geographic Operations
                8.4.3 Cerecor Inc Financial Information
                8.4.4 Cerecor Inc Product Positions/Portfolio
                8.4.5 Cerecor Inc Key Developments
        8.4.5 Chronos Therapeutics Ltd
                8.5.1 Business Description
                8.5.2 Chronos Therapeutics Ltd Geographic Operations
                8.5.3 Chronos Therapeutics Ltd Financial Information
                8.5.4 Chronos Therapeutics Ltd Product Positions/Portfolio
                8.5.5 Chronos Therapeutics Ltd Key Developments
        8.4.6 Corcept Therapeutics Inc
                8.6.1 Business Description
                8.6.2 Corcept Therapeutics Inc Geographic Operations
                8.6.3 Corcept Therapeutics Inc Financial Information
                8.6.4 Corcept Therapeutics Inc Product Positions/Portfolio
                8.6.5 Corcept Therapeutics Inc Key Developments
        8.4.7 Curemark LLC
                8.7.1 Business Description
                8.7.2 Curemark LLC Geographic Operations
                8.7.3 Curemark LLC Financial Information
                8.7.4 Curemark LLC Product Positions/Portfolio
                8.7.5 Curemark LLC Key Developments
        8.4.8 Eli Lilly and Company
                8.8.1 Business Description
                8.8.2 Eli Lilly and Company Geographic Operations
                8.8.3 Eli Lilly and Company Financial Information
                8.8.4 Eli Lilly and Company Product Positions/Portfolio
                8.8.5 Eli Lilly and Company Key Developments
        8.4.9 Ethypharm SA
                8.9.1 Business Description
                8.9.2 Ethypharm SA Geographic Operations
                8.9.3 Ethypharm SA Financial Information
                8.9.4 Ethypharm SA Product Positions/Portfolio
                8.9.5 Ethypharm SA Key Developments
        8.4.10 H. Lundbeck A/S
                8.10.1 Business Description
                8.10.2 H. Lundbeck A/S Geographic Operations
                8.10.3 H. Lundbeck A/S Financial Information
                8.10.4 H. Lundbeck A/S Product Positions/Portfolio
                8.10.5 H. Lundbeck A/S Key Developments
        8.4.11 Heptares Therapeutics Ltd
                8.11.1 Business Description
                8.11.2 Heptares Therapeutics Ltd Geographic Operations
                8.11.3 Heptares Therapeutics Ltd Financial Information
                8.11.4 Heptares Therapeutics Ltd Product Positions/Portfolio
                8.11.5 Heptares Therapeutics Ltd Key Developments
        8.4.12 Indivior Plc
                8.12.1 Business Description
                8.12.2 Indivior Plc Geographic Operations
                8.12.3 Indivior Plc Financial Information
                8.12.4 Indivior Plc Product Positions/Portfolio
                8.12.5 Indivior Plc Key Developments
        8.4.13 Kinnov Therapeutics SAS
                8.13.1 Business Description
                8.13.2 Kinnov Therapeutics SAS Geographic Operations
                8.13.3 Kinnov Therapeutics SAS Financial Information
                8.13.4 Kinnov Therapeutics SAS Product Positions/Portfolio
                8.13.5 Kinnov Therapeutics SAS Key Developments
        8.4.14 Kyorin Pharmaceutical Co Ltd
                8.14.1 Business Description
                8.14.2 Kyorin Pharmaceutical Co Ltd Geographic Operations
                8.14.3 Kyorin Pharmaceutical Co Ltd Financial Information
                8.14.4 Kyorin Pharmaceutical Co Ltd Product Positions/Portfolio
                8.14.5 Kyorin Pharmaceutical Co Ltd Key Developments
        8.4.15 Lohocla Research Corp
                8.15.1 Business Description
                8.15.2 Lohocla Research Corp Geographic Operations
                8.15.3 Lohocla Research Corp Financial Information
                8.15.4 Lohocla Research Corp Product Positions/Portfolio
                8.15.5 Lohocla Research Corp Key Developments
        8.4.16 Montisera Ltd
                8.16.1 Business Description
                8.16.2 Montisera Ltd Geographic Operations
                8.16.3 Montisera Ltd Financial Information
                8.16.4 Montisera Ltd Product Positions/Portfolio
                8.16.5 Montisera Ltd Key Developments
        8.4.17 Omeros Corp
                8.17.1 Business Description
                8.17.2 Omeros Corp Geographic Operations
                8.17.3 Omeros Corp Financial Information
                8.17.4 Omeros Corp Product Positions/Portfolio
                8.17.5 Omeros Corp Key Developments
        8.4.18 Opiant Pharmaceuticals Inc
                8.18.1 Business Description
                8.18.2 Opiant Pharmaceuticals Inc Geographic Operations
                8.18.3 Opiant Pharmaceuticals Inc Financial Information
                8.18.4 Opiant Pharmaceuticals Inc Product Positions/Portfolio
                8.18.5 Opiant Pharmaceuticals Inc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Alcohol Addiction Therapeutics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Alcohol Addiction Therapeutics Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Alcohol Addiction Therapeutics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Alcohol Addiction Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Alcohol Addiction Therapeutics Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Alcohol Addiction Therapeutics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Alcohol Addiction Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Alcohol Addiction Therapeutics Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Alcohol Addiction Therapeutics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Alcohol Addiction Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Alcohol Addiction Therapeutics Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Alcohol Addiction Therapeutics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Alcohol Addiction Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Alcohol Addiction Therapeutics Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Alcohol Addiction Therapeutics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Alcohol Addiction Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Alcohol Addiction Therapeutics: Market Segmentation 
FIG. 2 Global Alcohol Addiction Therapeutics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Alcohol Addiction Therapeutics Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Alcohol Addiction Therapeutics Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Alcohol Addiction Therapeutics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Alcohol Addiction Therapeutics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Alcohol Addiction Therapeutics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Alcohol Addiction Therapeutics Providers, 2019
FIG. 11 Global Alcohol Addiction Therapeutics Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Alcohol Addiction Therapeutics Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Alcohol Addiction Therapeutics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Alcohol Addiction Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Alcohol Addiction Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Alcohol Addiction Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Alcohol Addiction Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Alcohol Addiction Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Alcohol Addiction Therapeutics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1497

1308

OUR CLIENT